Archon Biosciences, a biotech startup putting AI to work designing novel biomolecules, has just emerged from stealth with an impressive $20 million in seed funding. The company aims to supercharge antibody treatments using specially designed protein “cages” that multiply their effects, opening up new opportunities in drug development. This is the first company to be […]
© 2024 TechCrunch. All rights reserved. For personal use only.
Related Posts
As SNAP Delays Continue, 10 Ways to Face Food Prices – Civil Eats
Catholic conference on mental health: Dignity is antedote to isolation – Vatican News
‘Let’s tackle that classic Donald Duck butt’: Fitness creator breaks down the 3 most common posture mistakes; expert-backed fixes that work – The Indian Express
D1 Training, Premier Athletic Fitness Brand Expands to Toledo – citybiz
6 Reasons To Move to Irvine, CA, and Why You’ll Love Living Here
Manychat Review: The Automation Chatbot You Need
Solve Rural Community Challenges the Idea Friendly Way – stories from IEDC
Pre-Halving Rally: Why Green Bitcoin and Bitcoin Minetrix are Going Up?
Leave a Reply